Matthew Croxen

Contact Overview Publications

Contact

Faculty of Medicine & Dentistry - Laboratory Medicine & Pathology Dept

Email: mcroxen@ualberta.ca
Phone: (780) 407-3766
Address: Mackenzie Health Science Centre
8440 - 112 St

Edmonton AB

T6G 2B7

Overview

Area of Study / Keywords

About

Dr. Matthew Croxen is currently appointed as Assistant Professor in the Department of Laboratory Medicine & Pathology in the Faculty of Medicine & Dentistry.

Research

Genomics, public health, infectious diseases

Featured Publications

Evolving strategy for an evolving virus: Development of real-time PCR assays for detecting all SARS-CoV-2 variants of concern

Pabbaraju K., Zelyas N., Wong A., Croxen M.A., Lynch T., Buss E., Murphy S., Shokoples S., Kanji J., Tipples G.

Journal of Virological Methods. 2022 September; 307 10.1016/j.jviromet.2022.114553

Analysis of emerging invasive Group B Streptoccocus serotype VIII in Alberta, Canada

21rst Lancefield International Symposium on Streptococci and Streptococcal Diseases. 2022 June;

Genomic characterization of invasive Streptococcus pneumoniae serogroup 20 in Alberta, Canada

International Society of Pneumonia and Pneumococcal Diseases. 2022 June;

Evolving detection strategies for an evolving virus: development of real-time PCR assays for all SARS-CoV-2 variants of concern.

CACMID/AMMI 2022. 2022 April;

Tracking SARS-CoV-2 variants of concern in Alberta, Canada.

CACMID/AMMI 2022. 2022 April;

How much do smear-negative patients really contribute to tuberculosis transmissions? Re-examining an old question with new tools

Asadi L., Croxen M., Heffernan C., Dhillon M., Paulsen C., Egedahl M.L., Tyrrell G., Doroshenko A., Long R.

eClinicalMedicine. 2022 January; 43 10.1016/j.eclinm.2021.101250

Characterization of swine influenza A(H1N2) variant, Alberta, Canada, 2020

Kanji J.N., Pabbaraju K., Croxen M., Detmer S., Bastien N., Li Y., Majer A., Keshwani H., Zelyas N., Achebe I., Jones C., Rutz M., Jacobs A., Lehman K., Hinshaw D., Tipples G.

Emerging Infectious Diseases. 2021 December; 27 (12):3045-3051 10.3201/eid2712.210298

SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1

Law J.L.M., Logan M., Joyce M.A., Landi A., Hockman D., Crawford K., Johnson J., LaChance G., Saffran H.A., Shields J., Hobart E., Brassard R., Arutyunova E., Pabbaraju K., Croxen M., Tipples G., Lemieux M.J., Tyrrell D.L., Houghton M.

Vaccine. 2021 September; 39 (40):5769-5779 10.1016/j.vaccine.2021.08.081

Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance

Zelyas N., Pabbaraju K., Croxen M.A., Lynch T., Buss E., Murphy S.A., Shokoples S., Wong A., Kanji J.N., Tipples G.

Microbiology Spectrum. 2021 September; 9 (1):1-10 10.1128/Spectrum.00315-21

Histoplasmosis acquired in Alberta, Canada: an epidemiological and genomic study

Dingle T.C., Croxen M.A., Fathima S., Shokoples S., Sonpar A., Saxinger L., Schwartz I.S.

The Lancet Microbe. 2021 May; 2 (5):e191-e197 10.1016/S2666-5247(20)30229-9

Phenotypic changes in group B streptococci grown in the presence of the polyols, erythritol, sorbitol and mannitol

Hulbah M., Croxen M.A., Tyrrell G.J.

BMC MICROBIOLOGY. 2021 May; 21 (1) 10.1186/s12866-021-02208-z

Retrospective testing of respiratory specimens for covid-19 to assess for earlier SARS-COV-2 infections in Alberta, Canada

Kanji J.N., Diggle M., Bulman D.E., Hume S., Taylor S., Kelln R., Haase S., Tomaszewski R., Walker C., Pabbaraju K., Li V., Croxen M., Zelyas N., Hinshaw D., Tipples G.

JAMMI. 2021 March; 6 (1):10-15 10.3138/jammi-2020-0035